Yancopoulos George's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed May 17, 2024
- Accession no.
- 0001968202-24-000094
- Filed
- May 17, 2024
- Trade date
- May 16, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions. Open-market sales total $48.6M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yancopoulos GeorgeCIK 0001226690 | Director, Officer (Bd. Co-Chair, President & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | Common Stock | SSaleDisposed | −907 | $967.40F2 | −$877,431.8 | 835,476 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −3,213 | $968.44F3 | −$3,111,597.72 | 832,263 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −9,501 | $969.39F4 | −$9,210,174.39 | 822,762 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −4,669 | $970.26F5 | −$4,530,143.94 | 818,093 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −4,922 | $971.56F6 | −$4,782,018.32 | 813,171 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −790 | $972.22F7 | −$768,053.8 | 812,381 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −2,653 | $973.80F8 | −$2,583,491.4 | 809,728 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −7,611 | $974.51F9 | −$7,416,995.61 | 802,117 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −9,242 | $975.48F10 | −$9,015,386.16 | 792,875 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −4,886 | $976.52F11 | −$4,771,276.72 | 787,989 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −1,227 | $977.38F12 | −$1,199,245.26 | 786,762 | Direct | |
| May 16, 2024 | Common Stock | SSaleDisposed | −379 | $978.18F13 | −$370,730.22 | 786,383 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 907 shares of Company stock on May 16, 2024 at prices ranging from $967.13 to $967.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 3,213 shares of Company stock on May 16, 2024 at prices ranging from $968.04 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 9,501 shares of Company stock on May 16, 2024 at prices ranging from $969.03 to $969.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 4,669 shares of Company stock on May 16, 2024 at prices ranging from $970.00 to $970.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 4,922 shares of Company stock on May 16, 2024 at prices ranging from $971.05 to $971.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 790 shares of Company stock on May 16, 2024 at prices ranging from $972.00 to $972.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 2,653 shares of Company stock on May 16, 2024 at prices ranging from $973.20 to $973.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 7,611 shares of Company stock on May 16, 2024 at prices ranging from $974.00 to $974.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 9,242 shares of Company stock on May 16, 2024 at prices ranging from $975.00 to $975.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 4,886 shares of Company stock on May 16, 2024 at prices ranging from $976.00 to $976.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F12
Represents volume-weighted average price of sales of 1,227 shares of Company stock on May 16, 2024 at prices ranging from $977.02 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F13
Represents volume-weighted average price of sales of 379 shares of Company stock on May 16, 2024 at prices ranging from $978.07 to $978.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.